The Evolving Role of the Biopharma and Medtech CIO: How to Succeed in Today's Digital Era

The role of the healthcare CIO is evolving. While CIOs still spend 80% of their time solving legacy IT issues—and just 20% of their time on digital strategy—top companies are placing more emphasis on digital, and it’s paying off. Biopharma and medtech companies that evolve the CIO role realize market share gains of around 7%.

Building effective digital strategies in the healthcare space is a competitive differentiator, with only 57% being categorized as digitally mature.

In this webinar, we will discuss how CIOs can build a digital strategy and leverage an Internet of Things platform that:

  • Provides security and privacy
  • Addresses complex regulatory burdens
  • Serves up analytics by turning massive amounts of data into insights
  • Delivers scalability across regions, brands, and health IT systems
  • Uses advanced AI, machine learning, and IoT technologies


Kal Patel, MD
CEO & Co-Founder, BrightInsight

Kal Patel, MD has over 20 years of experience in pharma, medtech and regulated digital health.

Prior to joining BrightInsight he was Chief Commercial Officer for Doctor on Demand, now the nation’s largest video-medicine provider, with backing from Andreessen Horowitz, Venrock, Google Ventures, and Qualcomm.

Kal founded and built Amgen’s Digital Health business unit where he had end-to-end responsibility for developing and commercializing a portfolio of digital products in connected devices, advanced algorithms/decision making and next-generation marketing, where he launched multiple regulated devices.

Prior to his focus on digital health at Amgen, Kal was the Global Marketing Lead for Enbrel, the company’s leading drug with over $6B in sales, where he created and launched major investments in novel clinical trials, innovative drug delivery devices, improved formulations and differentiated patient support programs. Kal started his Amgen career as Head of Corporate Strategy.

Kal also spent several years at Novartis Pharmaceuticals in various sales, marketing and account leadership roles. He began his professional career at the Boston Consulting Group where he worked for a broad portfolio of Healthcare companies across the U.S. and Europe. He transferred to the company’s Budapest office as part of BCG’s prestigious Ambassador program and was promoted early to Principal. Kal has also served as a Senior Advisor in Digital Health to the Boston Consulting Group where he helped C-level executives at pharma and medtech companies develop and execute digital health strategies.

Neveen Awad
Partner and Managing Director
Boston Consulting Group

Neveen is a Partner with the Detroit office of the Boston Consulting Group. She is a core member of the IT practice and health care practice. Neveen has deep IT change management experience, with a focus on ERP programs, and overall operations transformation experience.

  • Neveen has deep experience advising clients on critical technology topics including:
  • Led the Digital strategy and implementation planning for a health insurer that enabled 13% reduction in administrative costs and broader revenue growth opportunities
  • Led ERP planning, design, vendor selection, business case, and change management for a large system with multiple legal entities, leading to 20% cost avoidance off of $100M+ TCO
  • Developed Data architecture strategy for large national payer to enable exchange of external data to enable broader data analytics strategy
  • Executed an IT risk assessment for a large medical device company
  • Defined IT strategy and corresponding operating model for a national health insurer to enable strategic plan of significant growth, acquisition, and entrance into new business lines
  • Designed future-state platform strategy and implementation roadmap for a regional HC org. standing up a new line of business worth over $25M in cost savings and avoidance
  • Defined the overall strategy, and supporting IT and operations strategy, for a regional insurance company, identifying over $3B in potential revenue increase
  • Designed future-state platform strategy and implementation plan identifying actions worth over $25 million in cost savings and avoidance
  • Performed an audit of the information management strategy and supporting data architecture of a national payer
Anders Romare
CIO & Senior Vice President Global IT
Novo Nordisk
Catherine Dold
Contributing Editor
BioPharma Dive's Brand Studio

Catherine Dold, contributing editor for BioPharma Dive's Brand Studio, has written about health and the environment for The New York Times science pages, Smithsonian, Discover, Cosmopolitan and other national publications. She has also worked as a writer and editor for medical and scientific institutions, including the American Society of Nephrology, Sutter Health, Memorial Sloan-Kettering Cancer Center, the American Medical Association, the U.S. Fish and Wildlife Service, and the National Institutes of Health.

Please enter your details to listen to our 90-minute CIO Webinar.